Beauty Health (NASDAQ:SKIN) Price Target Raised to $1.65 at TD Cowen

Beauty Health (NASDAQ:SKIN) had its target price boosted by research analysts at TD Cowen from $1.50 to $1.65 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. TD Cowen’s price target points to a potential upside of 8.20% from the company’s previous close.

Several other equities analysts have also issued reports on the company. Jefferies Financial Group reaffirmed a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a research report on Wednesday, January 14th. Cowen restated a “hold” rating on shares of Beauty Health in a research report on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Beauty Health in a research report on Friday, October 31st. Zacks Research downgraded Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, Wall Street Zen cut Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $2.40.

Beauty Health Trading Up 5.9%

SKIN traded up $0.09 during trading on Wednesday, hitting $1.53. 225,189 shares of the stock traded hands, compared to its average volume of 340,002. The firm has a 50-day moving average of $1.44 and a 200 day moving average of $1.70. Beauty Health has a 12-month low of $0.78 and a 12-month high of $2.69. The firm has a market capitalization of $194.44 million, a P/E ratio of -6.93 and a beta of 1.16. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The business had revenue of $70.66 million during the quarter, compared to analysts’ expectations of $68.33 million. Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%. Equities research analysts anticipate that Beauty Health will post -0.25 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of SKIN. Woodline Partners LP raised its holdings in shares of Beauty Health by 255.9% in the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after buying an additional 4,263,997 shares during the period. Mirabella Financial Services LLP boosted its stake in shares of Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after purchasing an additional 2,734,728 shares during the period. Soleus Capital Management L.P. bought a new position in shares of Beauty Health in the second quarter worth about $1,910,000. Geode Capital Management LLC increased its stake in Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after buying an additional 496,963 shares during the period. Finally, Bank of America Corp DE grew its stake in Beauty Health by 482.3% in the 3rd quarter. Bank of America Corp DE now owns 336,382 shares of the company’s stock worth $669,000 after acquiring an additional 278,616 shares in the last quarter. Institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.